CUSIP H57830111
NLS PHARMACEUTICS LTD
12 institutions · $211.1K total · 1,511,976 shares
| # | Manager | Shares | Value | % of Total | Period |
|---|---|---|---|---|---|
| 1 | AIGH Capital Management LLC | 632,861 | $183.5K | 41.85% | 2023-03-31 |
| 2 | Ayrton Capital LLC | 170,100 | $17.9K | 11.25% | 2023-12-31 |
| 3 | WOLVERINE ASSET MANAGEMENT LLC | 245,000 | $3.2K | 16.20% | 2024-12-31 |
| 4 | Altium Capital Management LP | 200,000 | $2.3K | 13.22% | 2024-09-30 |
| 5 | CLEAR STREET LLC | 57,762 | $1.2K | 3.82% | 2025-06-30 |
| 6 | Clear Street Group Inc. | 57,762 | $1.0K | 3.82% | 2025-09-30 |
| 7 | Hudson Bay Capital Management LP | 71,356 | $821 | 4.71% | 2024-12-31 |
| 8 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 45,830 | $731 | 3.03% | 2025-09-30 |
| 9 | ARMISTICE CAPITAL, LLC | 12,500 | $250 | 0.82% | 2025-06-30 |
| 10 | CITADEL ADVISORS LLC | 18,381 | $237 | 1.21% | 2025-03-31 |
| 11 | UBS Group AG | 424 | $8 | 0.02% | 2025-09-30 |
| 12 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% | 2025-06-30 |